ELP1
Elongator complex protein 1
Also known as: DYS, ELP1_HUMAN, IKAP, IKBKAP, IKI3, TOT1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95163
- Gene
- ELP1
- Ensembl
- ENSG00000070061
- Chromosome
- 9
- Canonical length
- 1332 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
1332 residues, UniProt reviewed canonical sequence.
>O95163|ELP1
1 MRNLKLFRTL EFRDIQGPGN PQCFSLRTEQ GTVLIGSEHG LIEVDPVSRE VKNEVSLVAE
61 GFLPEDGSGR IVGVQDLLDQ ESVCVATASG DVILCSLSTQ QLECVGSVAS GISVMSWSPD
121 QELVLLATGQ QTLIMMTKDF EPILEQQIHQ DDFGESKFIT VGWGRKETQF HGSEGRQAAF
181 QMQMHESALP WDDHRPQVTW RGDGQFFAVS VVCPETGARK VRVWNREFAL QSTSEPVAGL
241 GPALAWKPSG SLIASTQDKP NQQDIVFFEK NGLLHGHFTL PFLKDEVKVN DLLWNADSSV
301 LAVWLEDLQR EESSIPKTCV QLWTVGNYHW YLKQSLSFST CGKSKIVSLM WDPVTPYRLH
361 VLCQGWHYLA YDWHWTTDRS VGDNSSDLSN VAVIDGNRVL VTVFRQTVVP PPMCTYQLLF
421 PHPVNQVTFL AHPQKSNDLA VLDASNQISV YKCGDCPSAD PTVKLGAVGG SGFKVCLRTP
481 HLEKRYKIQF ENNEDQDVNP LKLGLLTWIE EDVFLAVSHS EFSPRSVIHH LTAASSEMDE
541 EHGQLNVSSS AAVDGVIISL CCNSKTKSVV LQLADGQIFK YLWESPSLAI KPWKNSGGFP
601 VRFPYPCTQT ELAMIGEEEC VLGLTDRCRF FINDIEVASN ITSFAVYDEF LLLTTHSHTC
661 QCFCLRDASF KTLQAGLSSN HVSHGEVLRK VERGSRIVTV VPQDTKLVLQ MPRGNLEVVH
721 HRALVLAQIR KWLDKLMFKE AFECMRKLRI NLNLIYDHNP KVFLGNVETF IKQIDSVNHI
781 NLFFTELKEE DVTKTMYPAP VTSSVYLSRD PDGNKIDLVC DAMRAVMESI NPHKYCLSIL
841 TSHVKKTTPE LEIVLQKVHE LQGNAPSDPD AVSAEEALKY LLHLVDVNEL YDHSLGTYDF
901 DLVLMVAEKS QKDPKEYLPF LNTLKKMETN YQRFTIDKYL KRYEKAIGHL SKCGPEYFPE
961 CLNLIKDKNL YNEALKLYSP SSQQYQDISI AYGEHLMQEH MYEPAGLMFA RCGAHEKALS
1021 AFLTCGNWKQ ALCVAAQLNF TKDQLVGLGR TLAGKLVEQR KHIDAAMVLE ECAQDYEEAV
1081 LLLLEGAAWE EALRLVYKYN RLDIIETNVK PSILEAQKNY MAFLDSQTAT FSRHKKRLLV
1141 VRELKEQAQQ AGLDDEVPHG QESDLFSETS SVVSGSEMSG KYSHSNSRIS ARSSKNRRKA
1201 ERKKHSLKEG SPLEDLALLE ALSEVVQNTE NLKDEVYHIL KVLFLFEFDE QGRELQKAFE
1261 DTLQLMERSL PEIWTLTYQQ NSATPVLGPN STANSIMASY QQQKTSVPVL DAELFIPPKI
1321 NRRTQWKLSL LDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ELP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 28 nTPM
- retina: 23 nTPM
- cerebellum: 23 nTPM
- pituitary gland: 21 nTPM
- adrenal gland: 14 nTPM
- ovary: 14 nTPM
Single-cell type
- adrenal cortex cells: 330 nCPM
- somatotrophs: 127 nCPM
- lactotrophs: 115 nCPM
- retinal pigment epithelial cells: 107 nCPM
- retinal horizontal cells: 106 nCPM
- thyrotrophs: 92 nCPM
Immune cell
- basophil: 37 nTPM
- memory CD8 T-cell: 4.6 nTPM
- NK-cell: 4.5 nTPM
- MAIT T-cell: 4.4 nTPM
- naive CD8 T-cell: 4 nTPM
- memory CD4 T-cell: 3.5 nTPM
Brain region
- choroid plexus: 9.2 nTPM
- pons: 8.7 nTPM
- hypothalamus: 8.3 nTPM
- cerebellum: 6.1 nTPM
- thalamus: 6.1 nTPM
- medulla oblongata: 5.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ELP1.
Disease | AllUniProt
Conditions ELP1 is implicated in, by any mechanism.
- Neuropathy, hereditary sensory and autonomic, 3 (HSAN3) MIM:223900
- Medulloblastoma (MDB) MIM:155255
Disease | GeneticClinVar
433 pathogenic / likely-pathogenic of 2,695 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial dysautonomia
- Medulloblastoma
- ELP1-Associated Medulloblastoma
- Charcot-Marie-Tooth disease
- ELP1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.85
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- regulation of translation
- tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation
- tRNA wobble uridine modification
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WD40/YVTN repeat-like-containing domain superfamily
- Elongator complex protein 1
- ELP1, first N-terminal beta-propeller
- ELP1, N-terminal second beta-propeller
- ELP1, TPR domain
- ELP1, alpha-solenoid
- ELP1, three-helical bundle
- ELP1 first N-terminal beta-propeller
- ELP1 N-terminal second beta-propeller
- ELP1 TPR domain
- ELP1 alpha-solenoid
- ELP1 three-helix bundle
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ELP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ELP1 as an antibody target. Whether an autoantibody or antibody against ELP1 could matter depends on whether native ELP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ELP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ELP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...